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Retroviral vectors are ideally suited to the study of gene function, allowing efficient, stable expression. Many biological
systems (e.g., cell cycle, apoptosis) require the use of regulated expression systems. We therefore developed a regulated
retroviral vector system, TRA99, based on a tetracycline transactivator-dependent LTR, where the MMLV enhancer was
replaced with a tetracycline-response element. Using fluorescence-activated flow cytometric analysis of a destabilized green
fluorescent protein to monitor expression levels, we optimized the minimal promoter configuration with respect to both
activated and repressed transcription. The TRA99 vectors demonstrate regulated expression with activated levels compa-
rable to those of standard retroviral vectors and repressed levels indistinguishable from background. This was achieved
without using an internal promoter cassette, thus retaining the cis-packaging elements requisite for helper-mediated transfer.
© 2000 Academic Press
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tInitial approaches to understanding protein function
include transfer of the cognate gene, or mutated ver-
sions, into physiologically relevant cell systems wherein
their impact on cell functions is assessed. The require-
ment for efficient in vivo study of gene function is steadily
increasing as contemporary “genomics” provides an
abundance of new sequences with uncharacterized en-
coded function. Retroviral vectors are ideal vehicles for
efficiently providing stable, long-term expression of an
encoded protein function. In combination with method-
ologies for in vivo study of cell physiology, retroviral
vector-mediated gene transduction provides an opportu-
nity to efficiently evaluate the function of regulatory pro-
teins in a variety of different cell types. However, many
cell states (e.g., cell cycle, apoptosis) require the use of
conditional expression systems for efficient study. Vari-
ous inducible gene expression systems have been de-
veloped to address this need (1). The tetracycline (tet)-
inducible gene expression system originally described
by Gossen and Bujard (2) has been particularly success-
ful. The tet system utilizes cells constitutively expressing
the chimeric tet transactivator (tTA) comprising the Esch-
erichia coli Tn10 tetracycline repressor DNA-binding do-
ain and herpes simplex virus VP16 activation domain.
nteraction of the tTA dimer with the tet operator se-
uence (tetO), derived from the Tn10 operon, is regulated
y tetracycline (3). Tet conditional expression can bee
s
1 To whom reprint requests should be addressed. Fax: (650) 624-
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7engineered by linking a tetracycline response element
(TRE), a heptameric series of tetO sequences, to a min-
imal promoter. These TRE promoters are strongly acti-
vated by the binding of tTA dimers to the multimerized
tetO sites (2). This tTA-dependent expression is re-
pressed by the addition of tetracycline to the culture
medium. Repressed expression levels are determined by
the basal activity of the promoter (2). Most current tet-
inducible retroviral systems employ internal TRE expres-
sion cassettes (4, 5). This requires deletion of the pro-
moter/enhancer functions of the LTR to avoid interfer-
ence with the tet-regulatable promoter (e.g., self-
inactivating (SIN) vector) (6). An important feature of
retroviral vectors is that genes can also be transferred
from transduced cells to naı¨ve cells by supplying in trans
retroviral packaging functions. This is particularly useful
in functional screening approaches that employ retroviral
libraries or in vivo situations where controlled viral
pread is desired. To achieve conditional retroviral ex-
ression we engineered an MMLV-based retroviral vec-
or to contain tetracycline-regulated LTR promoter activ-
ty. We show that replacing the enhancer element of the
3 region of the LTR with the TRE renders viral expres-
ion tet-dependent. We evaluated different TRE promoter
onfigurations, with respect to both activated expression
nd negligible basal activity, by flow cytometric analysis
f green fluorescent protein (GFP) in live cell popula-
ions.
We constructed a basic retroviral vector, 96-dsGFP,ncoding a GFP with a C-terminal PEST sequence, de-
tabilized GFP (dsGFP). The dsGFP, which has a shorter
0042-6822/00 $35.00
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8 RAPID COMMUNICATIONprotein half-life than GFP, allows expression levels and
kinetics to be monitored in live cells by fluorescence-
activated flow cytometry (FACS) (Fig. 1A) (7). To achieve
conditional retroviral expression we replaced the 96-
dsGFP MMLV enhancer, comprising the two direct re-
peat regions, with a tetracycline-regulated element cas-
sette containing seven tet operator sequences (Fig. 1A).
This TRA99 vector was used to transfect the 293 cell-
based Phoenix A amphotropic packaging line, and infec-
tious virus was harvested after 48 h. A lung carcinoma-
derived A549 cell line that constitutively expresses the
tet transactivator, A549.tTA (Hitoshi et al., unpublished
ata), was infected with TRA99 retrovirus-containing me-
ium and assayed for expression by FACS. As shown in
FIG. 1. A TRE enhancer imparts tetracycline-regulated LTR expressi
regulated vector encoding dsGFP (TRA99-dsGFP). CRU5, 59 CMV-LTR c
PEST sequence (destabilized GFP); TRE, tetracycline-regulatable en
RA99-dsGFP-infected A549.tTA (B) and RBL.tTA (C) cells. Infected cel
dded to the culture medium and the cells were incubated for 72 h (1
haded region represents the mock-infected (background) gate.ig. 1B the TRA99 expression level is comparable to the
MLV-LTR-driven expression in infected A549.tTA cells,
c
tisplaying a geometric mean fluorescence intensity
geo.m.fl.) 100-fold greater than that of mock-infected
ells. The addition of the tetracycline analog, doxycycline
Dox), to the culture medium results in a 25-fold repres-
ion of TRA99 expression (Fig. 1B). The Dox treatment
as no effect on MMLV-LTR expression (data not shown).
otably, the mean fluorescence of TRA99 cells treated
ith Dox remains ;5-fold over background (11 vs 2.5
eo.m.fl. for mock-infected cells). To test whether the
igh basal expression level of TRA99 is a cell type-
pecific phenomenon, we created a tTA-expressing rat
asophillic leukemia (RBL) cell line, RBL.tTA. As shown
n Fig. 1C the TRA99 expression level is comparable to
he MMLV-LTR-driven expression in infected RBL.tTA
Schematic of the basic retroviral vector (96dsGFP) and a tetracycline-
ite LTR; C, retroviral packaging sequence; dsGFP, GFP with C-terminal
; MMLVPRO, MMLV LTR promoter. FACS analysis of 96-dsGFP- and
split into replica plates and incubated for 24 h. Dox (100 ng/ml) was
he dsGFP expression was analyzed in trypsinized cells by FACS. Theon. (A)
ompos
hancer
ls were
Dox). Tells and repressed by the addition of Dox. As noted for
he A549.tTA cells, TRA99 cells treated with Dox sustain
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10 RAPID COMMUNICATIONbasal expression (Fig. 1C, right panel). Thus the basal
expression is maintained in different cell types and may
be attributed to minimal MMLV promoter activity. The
MMLV promoter contains a CAAT box and an atypical
TATA element (Fig. 2A). For many applications, e.g., cell
cycle regulation, tight control of expression and very low
basal expression are desirable. Thus, we constructed a
TRA99 variant, TRA99/M, that has the TRE enhancer
element adjacent to the MMLV-TATA, removing the CAAT
box activity (Fig. 2A). As shown in Fig. 2B, the expression
level from activated TRA99/M was reduced ;5-fold (from
287 to 59 geo.m.fl.) in A549.tTA cells. A similar effect is
apparent in the RBL.tTA cells. This is likely due to the
nonconsensus MMLV-TATA box limiting transcriptional
preinitiation complex formation and reinitiation (8). We
therefore constructed the TRA99/T vector, which differs
from the TRA99/M by a single nucleotide change of
AATAAAA to TATAAAA in the MMLV-TATA box, creating
an optimal TATA box (Fig. 2A). As shown in Fig. 2B, the
activated expression levels of TRA99/T were indistin-
guishable from that of the MMLV-LTR in both the
A549.tTA carcinoma cells and the RBL.tTA basophils. To
determine whether this was a promoter-specific feature
we replaced the MMLV minimal promoter with a CMV
immediate-early (I/E) minimal promoter (Fig. 2A). As
shown in Fig. 2C, expression levels from the two tet-
regulated LTRs were identical in both cell types. These
data indicate that activated TRE-MMLV LTR expression
levels are dependent on the structure of the TATA box.
We next assessed the levels and kinetics of Dox-
regulated expression from the different TRE promoter
configurations. Infected A549.tTA FACS (Fig. 3A) and
RBL.tTA cells (Fig. 3B) were treated with Dox and the
FIG. 2levels of dsGFP expression were monitored at 24 and
72 h. The control 96-dsGFP vector expression levelswere constant throughout the experiment. TRA99/T and
TRA99/C showed similar activated expression levels,
equivalent to the 96-dsGFP vector (Fig. 3: 2Dox, 24 h).
Following Dox treatment, the level of dsGFP expression
falls ;15-fold within 24 h (e.g., Fig. 3B: 1Dox, 24 h; from
250 to 15 geo.m.fl.). At 72 h posttreatment, the levels of
TRA99/T and TRA99/C expression are indistinguishable
from background levels. This is in contrast to the levels
measured with the TRA99 vector (Fig. 1B). We next com-
pared the regulation of expression from a retroviral vec-
tor containing an internal tetracycline-regulated expres-
sion cassette, TRA (see Fig. 4). The TRA vector carries a
SIN mutation in the 39LTR that abolishes LTR expression
upon integration, allowing the TRE-CMV I/E promoter to
drive expression of the dsGFP gene without influence of
the LTR enhancer elements. As shown in Fig. 3B, the TRA
vector has ;10-fold higher activated expression levels
than the 96-dsGFP, TRA99/T, and TRA99/C vectors in
A549.tTA cells. This higher expression level is accompa-
nied by a greater basal activity. As seen at 72 h post-Dox
treatment, although the expression is repressed 200-fold,
a significant expression level is retained (11 geo.m.fl.).
This basal expression level is in fact similar to that seen
in the TRA99 vector (Fig. 1B). The same profile of tet-
regulated TRA, TRA99/T, and TRA99/C expression is ob-
served in the RBL.tTA cell line (Fig. 3C), although the
apparent expression levels are lower relative to A549
cells. Lower expression levels are also evident in the
96-dsGFP-infected RBL.tTA cells where dsGFP transcrip-
tion is MMLV-LTR-driven. Importantly, although the TRA
vector shows significant basal activity in the presence of
Dox, the TRA99/T and TRA99/C vectors are completely
repressed.
nuedNotably, the activated levels of expression between
the TRA99/C and the TRA vectors differ by almost 10-fold
b
r
11RAPID COMMUNICATIONin the proviral configuration (Fig. 4). Given that both
constructs utilize the same TRE-CMV promoter element,
the transcription rate should be similar. Hence, this re-
sult indicates that posttranscriptional regulation is an
important regulator of retroviral LTR expression levels.
The TRA vector utilizes a b-globin intron, resulting in
FIG. 3. Time-course analysis of TRE-LTR repression. Infected A549.tT
efore Dox was added. The expression of dsGFP was analyzed by FA
egion represents the mock-infected (background) gate.highly efficient splicing. Efficient RNA splicing is impor-
tant for maximal expression (as determined by proteinlevels) (9). In the retroviral life cycle, however, spliced
(Env-encoding) and unspliced (GagPol/genomic) tran-
scripts must coexist, limiting the extent of retroviral splic-
ing. Increasing the efficiency of RNA splice elements
flanking the packaging signal in retroviral vectors would
result in higher expression upon transfection but lower
d RBL.tTA (B) cells were split into replica plates and incubated for 24 h
wing incubation in the presence of Dox for 24 and 72 h. The shadedA (A) an
CS follovirus titers. This effectively limits the extent of LTR-me-
diated expression levels, regardless of the transcription
—Conti
12 RAPID COMMUNICATIONrate. Internal promoter constructs in reverse orientation
relative to LTR transcription circumvent the problem of
limited splicing efficiency. However, interference be-
tween the LTR and the internal promoter results in lower
FIG. 3titers and postintegration epigenetic effects (10). In ap-
plications such as functional genetic screening with ret-roviral cDNA libraries, the rescue of integrated provi-
ruses by introduction of helper viral packaging functions
can be used to demonstrate phenotypic transfer (Lorens
et al., submitted for publication). Self-inactivating vectors
nued(e.g., TRA) lose LTR expression and transcription of the
genomic region containing the packaging signal (11),
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13RAPID COMMUNICATIONprecluding their use in these approaches. Indeed, the
TRA vector is not rescued by retroviral helper viruses in
phenotypic transfer assays (data not shown).
Our results extend previous studies of regulated LTR-
mediated expression. Lindemann et al. (12) reported only
inor differences in basal expression levels from TRE
romoter constructs containing the CAAT and TATA
oxes. In contrast, our results demonstrate a significant
ackground from CAAT-containing constructs in two dif-
FIG. 4. LTR expression levels are limited posttranscriptionally. Compa
549.tTA cells were infected and analyzed for dsGFP expression b
ndependent experiment using a reduced amplifier gain to bring all GF
sGFP, 20 geo.m.fl.; TRA dsGFP, 200 geo.m.fl.). Schematics on the left i
hown below. m7, cap structure; AAAA, poly(A) tail. Line breaks denoterent cell types (Fig. 1). Importantly, we analyzed dsGFP
xpression in live cells by FACS. This methodology pro-
u
eides more information than common enzymatic (e.g.,
uciferase) reporter assays, which provide a single mea-
urement of the mean of the population. In contrast,
ACS analysis measures each individual cell as a dis-
inct data point and therefore reveals absolute infection
ates. This provides not only information regarding the
ean expression level of the population, but allows anal-
sis of the variance of expression levels. The contribu-
ion of each expressing cell may be analyzed and eval-
f expression levels from MMLV, TRE-LTR, and internal TRE promoters.
at 72 h. The geometric mean fluorescence was calculated in an
ssing cells (shaded region) on scale (96dsGFP, 21 geo.m.fl.; TRA99/C
the proviral configuration. Transcriptional orientation and splicing are
ng.rison o
y FACS
P-expre
ndicateated relative to the mean of the population. Retroviral
xpression is subject to integration site-specific effects
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14 RAPID COMMUNICATIONas determined by expression levels in single clones (13).
Thus, the variance of expression is important to under-
standing the nature of repressed expression levels. As
shown in Fig. 3, the variance of activated and repressed
expression levels is homogeneous. In the repressed
state no nonregulatable subpopulation was detected,
indicating that integration effects do not play a major role
in the regulated expression of these constructs.
The TRA99/T and TRA99/C vectors embody several
desirable characteristics: regulated expression with ac-
tivated levels comparable to traditional retroviral vectors
and repressed levels indistinguishable from background.
This was achieved without a competing internal pro-
moter cassette, thus retaining the cis-packaging ele-
ments requisite for helper-mediated transfer. Hence,
TRA99/T and TRA99/C vectors are particularly well
suited to assess gene function in systems where tight
control over LTR-mediated expression is critical.
Cell culture. A549.tTA cells, a lung carcinoma cell line
that constitutively expresses tTA (Y. Hitoshi, Rigel), was
maintained in F12K medium supplemented with 10%
heat-inactivated fetal bovine serum (JRH), 100 IU/ml pen-
icillin, and 100 mg/ml streptomycin. RBL cells, a rat ba-
sophilic leukemia cell line, were obtained from the ATCC
and maintained in Eagle’s modified essential medium
with Earle’s balanced salt solution, 15% heat-inactivated
fetal bovine serum (JRH), 100 IU/ml penicillin, and 100
mg/ml streptomycin. The RBL.tTA cell line was created by
infection (as described below) with the CtTAIH retroviral
vector (encoding the tet transactivator and IRES hygro-
mycin phosphotransferase gene; 15) and selection with
hygromycin (Boehringer Mannheim). Gene expression
from tet-regulated promoters was repressed by adding
100 ng/ml doxycycline (Sigma) to the culture medium.
Phoenix A packaging cells were grown in DMEM/10%
fetal bovine serum.
Retroviral vector construction. All retroviral constructs
were derived from the p96-dsG retroviral vector (J.B.L.,
unpublished results), which carries a composite CMV
promoter fused to the transcriptional start site of the
MMLV R-U5 region of the LTR, an extended packaging
sequence (C), deletion of the MMLV Gag start ATG, and
a multiple cloning region encoding a “destabilized” GFP
with a C-terminal PEST sequence (dsGFP, Clontech). The
TRA99 vector was constructed by replacing the U3 re-
gion of the 39LTR between the NheI site (2419 relative to
the start of transcription) and the SacI site (236) with a
XhoI–SacI fragment of the TRE region from the pTRA
vector (15). This places seven tandem tTA-binding sites
just upstream of the MMLV AATTAAA sequence (230)
through the common SacI site, creating TRA99/M. The
MLV promoter CAAT box was reconstituted by clon-
ng a SacI linker carrying the CAAT box (287 to 236:
59-GAGCTCGAACTAACCAATCAGTTCGCTTCTCGCTTC-
GTTCGCGCGCTTCTGCTCCCCGAGCTC) into the SacI
ite of TRA99/M, creating TRA99. The TRA99/T vectoras constructed by replacing the region between the
acI and the NarI sites (236 to 21) in TRA99/M with a
acI/NarI double-stranded oligonucleotide (59-GAGCTC-
ATATAAGAGCCCACAACCCCTCACTCGGGGCGCC),
hich changes the MMLV AATTAAA sequence (230) to
ATTAAA. The TRA99/C vector was constructed by re-
lacing the MMLV AATTAAA region between the SacI
nd the NarI sites (236 to 21) in TRA99/M with a SacI/
arI double-stranded oligonucleotide spanning the CMV
inimal promoter (59-GAGCTCGGTACCCGGGTCGAGTA-
GCGTGTACGGTGGGAGGCCTATATAAGCAGAGCTCG-
TTAGTGAACCGCGCC) from 238 to the transcriptional
tart site.
Retroviral transduction. Production of infectious retro-
iral vector particles in the 293-based Phoenix A pack-
ging cells and infection were carried out as described
n Swift et al. (14). Briefly, Phoenix A packaging cells were
ransfected with retroviral plasmid constructs and incu-
ated for 24 h. A549 or RBL culture medium was added
nd virus was collected 24 h later. Infections were car-
ied out with 0.45-mm-filtered virus-containing medium
by spin infection of trypsinized A549.tTA or RBL.tTA cells.
FACS. Flow cytometric analysis was conducted with
trypsized cells using a FACSCaliber flow cytometer (Bec-
ton Dickinson). FACS data were analyzed using the Win-
List (Verity Software House, Inc.) analysis program.
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